首页> 美国卫生研究院文献>Oncology Letters >Identification of a cancer stem cell-like side population in the HeLa human cervical carcinoma cell line
【2h】

Identification of a cancer stem cell-like side population in the HeLa human cervical carcinoma cell line

机译:HeLa人宫颈癌细胞系中癌干细胞样侧群的鉴定

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study aimed to identify the stem cell characteristics of side population (SP) cells sorted from the widely-used HeLa human cervical carcinoma cell line. The SP cells were sorted from the HeLa cell line using fluorescence-activating cell sorting (FACS). Stem cell characteristics of the SP cells, including proliferation, self-renewal, differentiation and the ability to form xenografts, were investigated in vitro and in vivo. The SP cells demonstrated strong tumorigenesis following in vivo transplantation into five to six-week-old female Balb/c mice. The SP cells were observed to be more resistant to chemotherapy and radiotherapy compared with non-side population (NSP) cells. A higher expression of CD133 was observed in the SP cells compared with the NSP cells following FACS. The results demonstrated that the SP cells from the HeLa human cervical carcinoma cell line exhibit stem cell characteristics in vitro and also have a strong ability to form tumors in vivo. The cell surface marker CD133 may serve as a potential molecular marker for the identification of cervical cancer stem cells (CSCs).
机译:本研究旨在鉴定从广泛使用的HeLa人宫颈癌细胞系中分选的侧群(SP)细胞的干细胞特征。使用荧光激活细胞分选术(FACS)从HeLa细胞系中分选SP细胞。在体外和体内研究了SP细胞的干细胞特性,包括增殖,自我更新,分化和形成异种移植物的能力。在体内移植到五到六周大的雌性Balb / c小鼠体内之后,SP细胞表现出了强大的肿瘤发生能力。与非侧群(NSP)细胞相比,观察到SP细胞对化学疗法和放射疗法更具抵抗力。与FACS后的NSP细胞相比,在SP细胞中观察到CD133的更高表达。结果表明,来自HeLa人宫颈癌细胞系的SP细胞在体外具有干细胞特性,并且在体内形成肿瘤的能力也很强。细胞表面标志物CD133可用作潜在的分子标志物,以鉴定宫颈癌干细胞(CSC)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号